Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-02

Clinical Trial Update: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intermittent vismodegib with photodynamic therapy in patients with basal cell carcinoma associated syndromes has completed; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vismodegib (Vismodegib)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Basal Cell Nevus Syndrome, Gorlin's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-11-02